Eirik Næss-Ulseth • 1956 • Oslo • 16 roles • 14 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
S SHARPXVIEW AS	Managing Director/CEO	1,081,200	368,855	30 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
S SKILLING SYSTEMER AS	Chairman	-	8,045,426	60 % directly
C CELLMOVER AS	Board Member	2,016,775	2,138,150	51.12 % directly 29.41 % indirectly 21.71 %
I INVENTRON AS	Chairman	-	123,077	32.96 % indirectly
S SHARPXVIEW AS	Chairman	1,081,200	368,855	30 % indirectly
E EQUANOSTIC AS	Chairman	6,570,665	10,182,831	23.43 % indirectly
V VITAE EVIDENCE AS	Board Member	533,106	-	22.9 % directly 1.41 % indirectly 21.49 %
C COREMINE VITAE AS	Chairman	744,512	5,232,635	22.61 % directly 0.15 % indirectly 22.46 %
A ARCTIC PHARMA AS	Chairman	1,018,191	2,005,323	22.08 % indirectly
T TOBORA AS	Board Member	10,500	-	15 % indirectly
B BIOMOLEX AS	Chairman	22,800	-	11.88 % directly 2.4 % indirectly 9.47 %
S SPERMATECH AS	Board Member	443,352	304,768	11.21 % indirectly
C COREMINE BIL	Board Member	-	-	-
P PUBGENE AS	Chairman	2,237,757	16,403,626	-
H HECOTRON AS	Alternate Member	-	1,926,344	-
H HECOTRON INDUSTRIELL ELEKTRONIKK AS	Board Member	15,819,739	14,506,555	-

Last update: Jun 11, 2025

Related industries

4

Culture and entertainment
Sports
Goods and trade
Purchase and sale
Services
Other services
Information and communication
Software

Direct relationships

5

HH
Håvard Hildeng Hauge1969
COREMINE BIL, PUBGENE AS, BIOMOLEX AS, VITAE EVIDENCE AS, COREMINE VITAE AS
BS
Bjørn Steen Skålhegg1959
ARCTIC PHARMA AS, SPERMATECH AS, TOBORA AS
GH
Gunnar Hvammen1963
ARCTIC PHARMA AS, SPERMATECH AS
EM
Espen Marcelius Gjems1978
COREMINE BIL, SPERMATECH AS
EN
Einar Nygård1962
INVENTRON AS, SHARPXVIEW AS

Shares owned by Eirik Næss-Ulseth

Name	Share class	Total operating income	Total equity	Share
S SKILLING SYSTEMER AS	Ordinære aksjer	0	8,045,426	60 % directly
I INVENTRON AS		0	123,077	32.96 % indirectly
S SHARPXVIEW AS		1,081,200	368,855	30 % indirectly
C CELLMOVER AS	Ordinære aksjer	2,016,775	2,138,150	29.41 % directly 29.41 % indirectly 21.71 %
E EQUANOSTIC AS		6,570,665	10,182,831	23.43 % indirectly
A ARCTIC PHARMA AS		1,018,191	2,005,323	22.08 % indirectly
R RHEUMATECH AS		7,000	0	15.58 % indirectly
S SKIPLUKKERN AS		7,430,425	2,258,864	15 % indirectly
T TOBORA AS		10,500	0	15 % indirectly
S SPERMATECH AS		443,352	304,768	11.21 % indirectly
R RAFX TECHNOLOGIES AS		1,633,692	182,942	5.95 % indirectly
B BIOMOLEX AS	NO0010162266	22,800	0	2.4 % directly 2.4 % indirectly 9.47 %
V VITAE EVIDENCE AS	Ordinære aksjer	533,106	0	1.41 % directly 1.41 % indirectly 21.49 %
C COREMINE VITAE AS	Ordinære aksjer	744,512	5,232,635	0.15 % directly 0.15 % indirectly 22.46 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025